Indian scientists have achieved a significant milestone by developing the country's first syrup for cancer patients, named Prevel. This groundbreaking innovation, a collaborative effort between Tata Memorial Hospital and the Advanced Center for Training Research and Education in Cancer (ACTREC), holds great potential for revolutionizing the treatment of blood cancer. Particularly beneficial for pediatric cancer patients, this oral suspension offers an effective alternative to conventional tablets. The pricing details for this promising drug are yet to be disclosed.
Breaking News
Wed, Oct 30, 2024
|All
All